Industry: Pharmaceuticals (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-06-06 | New | $895,076 | $895,076 | Equity Only | 06b | SEC link |
2013-05-10 | New | $200,100 | $200,100 | Equity Only | 06 | SEC link |
Name | Role |
---|---|
Sarat Maharaj | Director |
Christopher Micetich | Director, Executive |
Ronald Odynsk | Director |
Leonard Post | Director |